User profiles for Patrick CN Rensen
Patrick RensenProfessor of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands Verified email at lumc.nl Cited by 21174 |
Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting
PCN Rensen, RLA de Vrueh, J Kuiper… - Advanced drug delivery …, 2001 - Elsevier
Lipoproteins are endogenous particles that transport lipids through the blood to various cell
types, where they are recognised and taken up via specific receptors. These particles are, …
types, where they are recognised and taken up via specific receptors. These particles are, …
Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis
…, JFP Berbée, LM Havekes, PCN Rensen - Atherosclerosis, 2013 - Elsevier
Dyslipidemia and inflammation are well known causal risk factors the development of
atherosclerosis. The interplay between lipid metabolism and inflammation at multiple levels in …
atherosclerosis. The interplay between lipid metabolism and inflammation at multiple levels in …
Role of brown fat in lipoprotein metabolism and atherosclerosis
G Hoeke, S Kooijman, MR Boon, PCN Rensen… - Circulation …, 2016 - Am Heart Assoc
Atherosclerosis, for which hyperlipidemia is a major risk factor, is the leading cause of morbidity
and mortality in Western society, and new therapeutic strategies are highly warranted. …
and mortality in Western society, and new therapeutic strategies are highly warranted. …
[HTML][HTML] Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytesin vitro and in vivo
PCN Rensen, LAJM Sliedregt, M Ferns… - Journal of biological …, 2001 - ASBMB
The asialoglycoprotein receptor (ASGPr) on hepatocytes plays a role in the clearance of
desialylated proteins from the serum. Although its sugar preference (N-acetylgalactosamine (…
desialylated proteins from the serum. Although its sugar preference (N-acetylgalactosamine (…
[HTML][HTML] Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development
Brown adipose tissue (BAT) combusts high amounts of fatty acids, thereby lowering plasma
triglyceride levels and reducing obesity. However, the precise role of BAT in plasma …
triglyceride levels and reducing obesity. However, the precise role of BAT in plasma …
Inflammasome is a central player in the induction of obesity and insulin resistance
…, J Romijn, PCN Rensen… - Proceedings of the …, 2011 - National Acad Sciences
Inflammation plays a key role in the pathogenesis of obesity. Chronic overfeeding leads to
macrophage infiltration in the adipose tissue, resulting in proinflammatory cytokine production…
macrophage infiltration in the adipose tissue, resulting in proinflammatory cytokine production…
[PDF][PDF] The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity
…, JA Van Diepen, SAA van den Berg, PCN Rensen… - Cell metabolism, 2010 - cell.com
Obesity-induced inflammation originating from expanding adipose tissue interferes with
insulin sensitivity. Important metabolic effects have been recently attributed to IL-1β and IL-18, …
insulin sensitivity. Important metabolic effects have been recently attributed to IL-1β and IL-18, …
Selective liver targeting of antivirals by recombinant chylomicrons—a new therapeutic approach to hepatitis B
PCN Rensen, MCM Van Dijk, EC Havenaar… - Nature medicine, 1995 - nature.com
Hepatitis B virus (HBV) infection is the world's most important chronic virus infection. No safe
and effective treatment is available at present, and clinical exploration of promising antiviral …
and effective treatment is available at present, and clinical exploration of promising antiviral …
Butyrate reduces appetite and activates brown adipose tissue via the gut-brain neural circuit
Objective Butyrate exerts metabolic benefits in mice and humans, the underlying mechanisms
being still unclear. We aimed to investigate the effect of butyrate on appetite and energy …
being still unclear. We aimed to investigate the effect of butyrate on appetite and energy …
[HTML][HTML] ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated …
FG Schaap, PCN Rensen, PJ Voshol, C Vrins… - Journal of biological …, 2004 - ASBMB
ApoAV has been discovered recently as a novel modifier of triglyceride (TG) metabolism,
but the pathways involved are currently unknown. To gain insight into the function of apoAV, …
but the pathways involved are currently unknown. To gain insight into the function of apoAV, …